More on IPXL

- Summary
- Chart
- Profile
- Historical


- Earnings (-100.0% Growth)
- Ratings (3.7 Score)
- Holders
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/9/16)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

IPXL Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 366.85M
Short-term investments
Accounts receivable, net 237.45M
Inventory, net 148.08M
Deferred product manufacturing costs
Deferred income taxes
Prepaid expenses and other current assets 24.34M
Total current assets 776.72M
Property, plant and equipment, net 223.48M
Deferred product manufacturing costs
Deferred income taxes, net 597K
Other assets 58.97M
Goodwill 208.4M
Total assets 1.85B
Current liabilities:
Accounts payable 50.52M
Accrued expenses 201.81M
Accrued income taxes payable
Accrued profit sharing and royalty expenses 13.62M
Deferred revenue
Total current liabilities 265.95M
Deferred revenue
Other liabilities 37.16M
Total liabilities 776.55M
Commitments and contingencies (Note 8) 0
Stockholders' equity:
Preferred Stock, $ 0.01 par value, 2,000,000 shares authorized, 0 shares outstanding at June 30, 2011 and December 31, 2010 0
Common stock, $ 0.01 par value, 90,000,000 shares authorized and 65,872,062 and 64,721,041 shares issued at June 30, 2011 and December 31, 2010, respectively 741K
Additional paid-in capital 525.18M
Treasury stock-243,729 shares -2.16M
Accumulated other comprehensive income -7.49M
Retained earnings 557.11M
Stockholders' Equity Attributable to Parent, Total
Noncontrolling interest
Total stockholders' equity 1.07B
Total liabilities and stockholders' equity 1.85B